ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $86,344 | -82.9% | 13,366 | -80.0% | 0.00% | – |
| Q1 2023 | $504,411 | -32.9% | 66,898 | -9.9% | 0.00% | – |
| Q4 2022 | $752,112 | -77.9% | 74,246 | -78.4% | 0.00% | -100.0% |
| Q3 2022 | $3,402,000 | +673.2% | 343,938 | +731.7% | 0.00% | – |
| Q2 2022 | $440,000 | -27.8% | 41,355 | -33.8% | 0.00% | – |
| Q1 2022 | $609,000 | -46.2% | 62,425 | -21.2% | 0.00% | – |
| Q4 2021 | $1,132,000 | -10.9% | 79,191 | +24.9% | 0.00% | – |
| Q3 2021 | $1,270,000 | +40.8% | 63,407 | +54.6% | 0.00% | – |
| Q2 2021 | $902,000 | +767.3% | 41,018 | +1236.5% | 0.00% | – |
| Q1 2021 | $104,000 | – | 3,069 | +38262.5% | 0.00% | – |
| Q4 2020 | $0 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |